Mednet Logo
HomePulmonologyQuestion

Will you incorporate ensifentrine in the treatment regimen of patients with COPD on baseline dual or triple inhaler therapy?

1 Answers
Mednet Member
Mednet Member
Pulmonology · IU Health Arnett Hospital

Novel bronchodilator. ENHANCE 1 and 2 showed improvement of lung function but cost can be a factor. $2,950 per month.

Register or Sign In to see full answer

Will you incorporate ensifentrine in the treatment regimen of patients with COPD on baseline dual or triple inhaler therapy? | Mednet